Can Pfizer Stock Double Your Money in 3 Years?
Pfizer (NYSE: PFE) has been a losing play for investors over the past 12 months. To wit: The drugmaker's stock has fallen by a whopping 28.8% over this period. Since the start of 2023, investors have shown a magnetic attraction to a select group of companies such as Eli Lilly (NYSE: LLY), Crispr Therapeutics, Microsoft, and Nvidia, causing their shares to dramatically outperform the broader market.